Tag: Cancer: Ovarian
Genetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
Study shows that polygenic score does not modify the 13 percent reduction in ovarian cancer risk seen with aspirin
Lifetime Ovulatory Years Linked to Epithelial Ovarian Cancer
Individual lifetime ovulatory years components associated with epithelial ovarian cancer apart from age at menarche
Ultra-Processed Food Intake Linked to Cancer Burden, Mortality
Risk for cancer, specifically ovarian cancer, increased with each 10 percent increment in UPF consumption
Experts Say Even Low-Risk Women Should Remove Fallopian Tubes to Avoid Cancer
The Ovarian Cancer Research Alliance released new guidance advising removal of fallopian tubes when planning a separate gynecologic operation
Acupuncture, Acupressure Beneficial in Gynecologic Cancer Surgery Setting
Improvement seen in severe pain, anxiety for treatment groups receiving preoperative touch/relaxation with or without intraoperative acupuncture
Health Care Access May Affect Receipt of Therapy in Ovarian Cancer
Among ovarian cancer patients, non-Hispanic Blacks remained less likely than non-Hispanic Whites to initiate systemic therapy even after adjustment for health care access scores
Surveillance Feasible for Women Deferring Prophylactic Salpingo-Oophorectomy
Ovarian cancer surveillance has modeled sensitivity and specificity of 87.5 and 99.9 percent and is cost-saving
Frequent Aspirin Use Tied to Lower Ovarian Cancer Risk
Association remains regardless of the presence of most other risk factors for ovarian cancer
Patient-Reported Outcomes + Wearable Data Predict Postop Adverse Events
Findings seen among women with gynecologic cancers followed for four weeks
Trametinib Slows Recurrent Low-Grade Serous Ovarian Carcinoma
Median progression-free survival significantly prolonged with trametinib versus one of five standard-of-care treatment options